Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Cognitive Effects of Electroconvulsive Therapy in Clozapine-Resistant Schizophrenia

NCT02159001 is registered in ClinicalTrials.gov with Niuvanniemi Hospital as lead sponsor.

NCT NCT02159001
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02159001 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Cognitive Effects of Electroconvulsive Therapy in Clozapine-Resistant Schizophrenia
Lead sponsor
Niuvanniemi Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
June 30, 2014
Completion date
June 30, 2018
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizoaffective disorder, schizophrenia